首页> 外文期刊>General Pharmacology >Endothelial dysfunction in DOCA-salt hypertension: possible involvement of prostaglandin endoperoxides.
【24h】

Endothelial dysfunction in DOCA-salt hypertension: possible involvement of prostaglandin endoperoxides.

机译:DOCA盐高血压中的内皮功能障碍:前列腺素内过氧化物的可能参与。

获取原文
获取原文并翻译 | 示例
       

摘要

The effects of the arachidonic acid metabolism inhibitors on the acetylcholine responses of aortae from control (CR) and deoxycorticosterone acetate (DOCA)-salt hypertensive (HR) rats were investigated. The acetylcholine decreased response observed in HR [relaxation (%): CR 95.5+/-2.7, n = 4; HR 52.0+/-6.3, n = 5, p < 0.05] was restored by the cyclooxygenase inhibitor piroxicam [relaxation (%): CR 99.8+/-0.2, n = 4; HR 86.0+/-4.0, n = 5] and by the thromboxane synthetase inhibitor and the thromboxane A2/prostaglandin H2 receptor antagonist ridogrel [relaxation (%): CR 92.1+/-4.4, n = 7; HR 93.1+/-2.0, n = 7] but not by the inhibitors of thromboxane synthetase, prostacyclin synthetase, cytochrome P-450 monooxygenase, and lipoxygenase. So, endoperoxide intermediates seem to be involved in the decreased endothelium-dependent relaxation to acetylcholine in DOCA-salt hypertension.
机译:研究了花生四烯酸代谢抑制剂对来自对照(CR)和醋酸脱氧皮质酮(DOCA)-盐高血压(HR)大鼠主动脉乙酰胆碱反应的影响。在HR中观察到的乙酰胆碱降低的反应[松弛(%):CR 95.5 +/- 2.7,n = 4;通过环氧合酶抑制剂吡罗昔康恢复了HR 52.0 +/- 6.3,n = 5,p <0.05] [松弛(%):CR 99.8 +/- 0.2,n = 4; HR 86.0 +/- 4.0,n = 5],并由血栓烷合成酶抑制剂和血栓烷A2 /前列腺素H2受体拮抗剂利多格雷[松弛(%):CR 92.1 +/- 4.4,n = 7; HR 93.1 +/- 2.0,n = 7],但不受血栓烷合成酶,前列环素合成酶,细胞色素P-450单加氧酶和脂加氧酶抑制剂的影响。因此,在DOCA-盐高血压中,内过氧化物中间体似乎参与了内皮依赖性对乙酰胆碱的松弛减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号